KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Other Non-Current Assets (2016 - 2025)

Quest Diagnostics' Other Non-Current Assets history spans 17 years, with the latest figure at $270.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 5.88% year-over-year to $270.0 million; the TTM value through Dec 2025 reached $270.0 million, up 5.88%, while the annual FY2025 figure was $270.0 million, 5.88% up from the prior year.
  • Other Non-Current Assets for Q4 2025 was $270.0 million at Quest Diagnostics, down from $296.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $296.0 million in Q3 2025 and bottomed at $132.0 million in Q3 2022.
  • The 5-year median for Other Non-Current Assets is $173.0 million (2021), against an average of $195.1 million.
  • The largest annual shift saw Other Non-Current Assets dropped 22.16% in 2022 before it surged 82.55% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $163.0 million in 2021, then decreased by 11.66% to $144.0 million in 2022, then soared by 37.5% to $198.0 million in 2023, then increased by 28.79% to $255.0 million in 2024, then grew by 5.88% to $270.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Other Non-Current Assets are $270.0 million (Q4 2025), $296.0 million (Q3 2025), and $271.0 million (Q2 2025).